Thyroid Nodules

On this page

Basics & Presentation - Neck's Lumpy Riddles

  • Definition: Discrete thyroid lesion, radiologically distinct from parenchyma.
  • Prevalence: Common; ↑ age, female, iodine deficiency, radiation exposure. Palpable 4-7%, ultrasound 50-70%.
  • Etiology:
    • Benign (>90%): Colloid nodules, adenomas, cysts, Hashimoto's thyroiditis.
    • Malignant (<10%): PTC (commonest), FTC, MTC, anaplastic, lymphoma.
  • Clinical Features:

    ⭐ Most thyroid nodules are asymptomatic and benign, discovered incidentally.

    • Painless neck mass (most common).
    • Compressive symptoms (if large): Dysphagia, dyspnea, hoarseness (RLN involvement).
    • Functional nodule (rare): Symptoms of thyrotoxicosis.
    • Pain (uncommon): Suggests hemorrhage into cyst or thyroiditis.
    • Red flags for malignancy: Rapid growth, firm/hard, fixed, vocal cord palsy, cervical lymphadenopathy, age <20 or >60. oka

Imaging & Labs - Scan & Scope Secrets

  • Initial Labs:

    • TSH: Best initial test.
    • If TSH ↓: Thyroid Scintigraphy ($^{123}$I or $^{99m}$Tc).
    • If TSH normal/↑: Proceed to USG.
    • Serum Calcitonin: If Medullary Thyroid Carcinoma (MTC) suspected (e.g., family hx, MEN2).
  • Ultrasound (USG) Neck:

    • Primary imaging for all palpable/incidental nodules.
    • Key for risk stratification (TIRADS).
    • High-risk features: Solid, hypoechoic, microcalcifications, irregular margins, taller-than-wide, extrathyroidal extension, suspicious lymph nodes.
  • Thyroid Scintigraphy:

    • Indicated for low TSH nodules.
    • Hot nodule (hyperfunctioning): ↓ malignancy risk.
    • Cold nodule (hypofunctioning): ↑ malignancy risk (5-15%).

⭐ A suppressed TSH suggests a hyperfunctioning ("hot") nodule, which is rarely malignant; further evaluation with thyroid scintigraphy is indicated.

FNA & Bethesda - Bethesda & Beyond

  • FNA (Fine Needle Aspiration): Key diagnostic tool for thyroid nodules, ideally USG-guided for accuracy.
  • The Bethesda System (TBSRTC): Standardizes thyroid cytology reporting globally, crucial for guiding subsequent management decisions.

Bethesda Categories, Risk of Malignancy (ROM) & Management:

  • I: ND/US (Non-Diagnostic/Unsatisfactory)
    • ROM: 5-10%
    • Mgmt: Repeat FNA, preferably USG-guided.
  • II: Benign
    • ROM: 0-3%
    • Mgmt: Clinical and USG follow-up.
  • III: AUS/FLUS (Atypia/Follicular Lesion of Undetermined Significance)
    • ROM: 10-30%
    • Mgmt: Options include Repeat FNA, molecular markers, or diagnostic surgery (lobectomy).
  • IV: FN/SFN (Follicular Neoplasm/Suspicious for FN)
    • ROM: 25-40%
    • Mgmt: Diagnostic lobectomy; molecular markers can aid risk stratification.
  • V: SM (Suspicious for Malignancy)
    • ROM: 45-75%
    • Mgmt: Surgical intervention: (Near)Total Thyroidectomy or Lobectomy.
  • VI: Malignant
    • ROM: 97-99%
    • Mgmt: Therapeutic surgery: (Near)Total Thyroidectomy; lobectomy for select low-risk cancers.

⭐ Bethesda VI (Malignant) has a 97-99% risk of malignancy, typically requiring surgical intervention.

Management Flow based on Bethesda:

Management Algorithms - Surgical & Other Sorties

  • Benign (II): Observe; Rpt USG/FNA if ↑size/symptoms. Surgery if compressive/cosmetic.
  • Indeterminate (III, IV, V):
    • AUS/FLUS (III): Rpt FNA, molecular markers, diagnostic lobectomy.
    • SFN/HCN (IV): Diagnostic lobectomy.
    • Susp. Malignancy (V): (Near) Total thyroidectomy or diagnostic lobectomy.
  • Malignant (VI):
    • DTC (PTC/FTC):
      • MicroCa (<1cm, low-risk): Lobectomy.
      • Else: Total thyroidectomy + CND. Lateral ND if nodes+.
    • Medullary Ca: Total thyroidectomy + CND.
    • Anaplastic Ca: Palliative (surgery, EBRT, chemo).
  • Post-op DTC: RAI ablation (high-risk), TSH suppression.

⭐ Papillary Thyroid Carcinoma (PTC) is the most common thyroid malignancy and often has an excellent prognosis with appropriate treatment.

High‑Yield Points - ⚡ Biggest Takeaways

  • FNAC is the cornerstone for thyroid nodule evaluation.
  • Most nodules are benign; papillary carcinoma is the commonest malignancy.
  • The Bethesda system for FNAC reporting guides management.
  • "Cold" nodules on thyroid scan are more suspicious for malignancy.
  • Key malignancy risk factors: radiation history, rapid growth, hard/fixed nodule, lymphadenopathy.
  • Initial test: TSH. If TSH is normal/high, FNAC is next.
  • Solitary nodules often warrant more concern than multiple nodules in a goiter.

Practice Questions: Thyroid Nodules

Test your understanding with these related questions

Metastases from follicular carcinoma should be treated by:

1 of 5

Flashcards: Thyroid Nodules

1/10

What is the surgical management in MTC without LN involvement?_____

TAP TO REVEAL ANSWER

What is the surgical management in MTC without LN involvement?_____

Total thyroidectomy + Central neck dissection (prophylactic)

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial